Literature DB >> 1497677

Vitamin E protects nerve cells from amyloid beta protein toxicity.

C Behl1, J Davis, G M Cole, D Schubert.   

Abstract

The amyloid beta protein (ABP) is a 40 to 42 amino acid peptide which accumulates in Alzheimer's disease plaques. It has been demonstrated that this peptide and a fragment derived from it are cytotoxic for cultured cortical nerve cells. It is shown here that ABP and an internal fragment encompassing residues 25 to 35 (beta 25-35) are cytotoxic to a clone of PC12 cells at concentrations above 1 x 10(-9)M and to several other cell lines at higher concentrations. Between 10(-9) and 10(-11) M beta 25-35 protects PC12 cells from glutamate toxicity. The antioxidant and free radical scavenger vitamin E inhibits ABP induced cell death. These results have implications regarding the prevention and treatment of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1497677     DOI: 10.1016/0006-291x(92)90837-b

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  91 in total

1.  Sesaminol glucosides protect β-amyloid induced apoptotic cell death by regulating redox system in SK-N-SH cells.

Authors:  Min Young Um; Ji Yun Ahn; Mi Kyung Kim; Tae Youl Ha
Journal:  Neurochem Res       Date:  2011-12-06       Impact factor: 3.996

2.  Estrogen-dependent transcription of the NEL-like 2 (NELL2) gene and its role in protection from cell death.

Authors:  Eun Jung Choi; Dong Hee Kim; Jae Geun Kim; Dong Yeol Kim; Jung Dae Kim; Ok Ju Seol; Choon Soo Jeong; Jeong Woo Park; Min Young Choi; Sung Goo Kang; Maria E Costa; Sergio R Ojeda; Byung Ju Lee
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

3.  Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity.

Authors:  C Hertel; E Terzi; N Hauser; R Jakob-Rotne; J Seelig; J A Kemp
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

4.  Neuroprotection in Alzheimer's disease - new strategies for treatment.

Authors:  A Nordberg
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 5.  Staying connected: synapses in Alzheimer disease.

Authors:  Hyoung-Gon Lee; Paula I Moreira; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

6.  Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid.

Authors:  J J Yan; J Y Cho; H S Kim; K L Kim; J S Jung; S O Huh; H W Suh; Y H Kim; D K Song
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 7.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 8.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

9.  Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ.

Authors:  H Lassmann; C Bancher; H Breitschopf; J Wegiel; M Bobinski; K Jellinger; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Lower serum uric acid levels in cerebral amyloid angiopathy: a pilot study.

Authors:  Qi Hu; Anding Liu; Mengyang Huang; Luo Cheng; Huicong Kang; Feng Xu; Xiaoyan Liu; Lifei Lian; Qiming Liang; Hong Jiang; Cuntai Zhang; Suiqiang Zhu
Journal:  Neurol Sci       Date:  2014-01-25       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.